ArticleJournal of hematology & oncology2018
Activity of pembrolizumab in relapsed/refractory NK/T-cell lymphoma.
Xin Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
127 papers cite itlatest 60 shown
this papertrialcites it
ArticleJournal of hematology & oncology2018
Xin Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.